• Gene Therapy Takes Center Stage at 2019 NORD Summit
  • HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • StrideBio, Sarepta Partner to Advance Gene Therapies for Dravet, Other Rare Diseases
  • Fintepla Lowers Seizure Frequency in Children and Teens with Dravet, Phase 3 Studies Report
  • NICE Favors Adding Epidyolex, Cannabidiol Oral Solution, to NHS for Dravet Patients in England
  • Rare Disease Film Festival Highlights Patient and Researcher Unity
  • Fintepla Safely and Effectively Eases Seizures in Young Children with Dravet, Extension Study Finds
  • Treating Dravet Means Being Open to Variety of Care and Therapies, Review Study Says
  • NeuCyte, Trillium Therapeutics Team Up to Develop New Therapy for Drug-resistant Epilepsies
  • Soticlestat Can Reduce Seizure Frequency in Adults With Dravet, Other Rare Epilepsies, Initial Data Shows
  • Seizures in Dravet Patients May Be Associated with Abnormal Serotonin System, Preclinical Study Suggests
  • Cannabis-based Zygel Helps Reduce Seizures in Childhood Epilepsy Syndromes, Trial Reports